Free from Publisher

A pragmatic guide to choosing biologic therapies in severe asthma

JE Kavanagh, AP Hearn, DJ Jackson - Breathe, 2021 - Eur Respiratory Soc
There are now several monoclonal antibody (mAb) therapies (“biologics”) available to treat
severe asthma. Omalizumab is an anti-IgE mAb and is licensed in severe allergic asthma …
被引用次数：30 相关文章

A pragmatic guide to choosing biologic therapies in severe asthma

JE Kavanagh, AP Hearn, DJ Jackson - Breathe, 2021 - kclpure.kcl.ac.uk
There are now several monoclonal antibody (mAb) therapies (“biologics”) available to treat
severe asthma. Omalizumab is an anti-IgE mAb and is licensed in severe allergic asthma …
[HTML] nih.gov

[HTML][HTML] A pragmatic guide to choosing biologic therapies in severe asthma

JE Kavanagh, AP Hearn, DJ Jackson - Breathe, 2021 - ncbi.nlm.nih.gov
There are now several monoclonal antibody (mAb) therapies (“biologics”) available to treat
severe asthma. Omalizumab is an anti-IgE mAb and is licensed in severe allergic asthma …

A pragmatic guide to choosing biologic therapies in severe asthma.

JE Kavanagh, AP Hearn, DJ Jackson - Breathe (Sheffield, England), 2021 - europepmc.org
There are now several monoclonal antibody (mAb) therapies (“biologics”) available to treat
severe asthma. Omalizumab is an anti-IgE mAb and is licensed in severe allergic asthma …
[HTML] ersjournals.com

[HTML][HTML] A pragmatic guide to choosing biologic therapies in severe asthma

JE Kavanagh, AP Hearn, DJ Jackson - Breathe, 2021 - Eur Respiratory Soc
There are now several monoclonal antibody (mAb) therapies (“biologics”) available to treat
severe asthma. Omalizumab is an anti-IgE mAb and is licensed in severe allergic asthma …

A pragmatic guide to choosing biologic therapies in severe asthma

JE Kavanagh, AP Hearn… - Breathe (Sheffield …, 2021 - pubmed.ncbi.nlm.nih.gov
There are now several monoclonal antibody (mAb) therapies (" biologics") available to treat
severe asthma. Omalizumab is an anti-IgE mAb and is licensed in severe allergic asthma …

A pragmatic guide to choosing biologic therapies in severe asthma.

JE Kavanagh, AP Hearn, DJ Jackson - Breathe (Sheffield, England), 2021 - europepmc.org
There are now several monoclonal antibody (mAb) therapies (“biologics”) available to treat
severe asthma. Omalizumab is an anti-IgE mAb and is licensed in severe allergic asthma …